Germany· DE-A57-6a3b731469ccf541
Maintelyte
A medicinal product containing magnesium chloride hexahydrate, potassium chloride, sodium chloride, sodium acetate trihydrate, glucose monohydrate ph. eur., registered in Germany by Baxter Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate, Glucose Monohydrate Ph. Eur.
- Manufacturer
- Baxter Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Magnesium chloride hexahydrate, potassium chloride, sodium chloride, sodium acetate trihydrate, glucose monohydrate ph. eur. in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaACID CONCENTRATE A1267CHIEF MEDICAL SUPPLIES LTD
- CzechiaPLASMALYTE S GLUKÓZOUBAXTER CZECH spol. s r.o., Praha
- NorwayGlucose-Na-K BaxterBaxter Medical AB
- SwedenGlucose-Na-K Baxter 100 mg/ml Infusionsvätska, lösningBaxter Medical AB
- FinlandGlucose-Na-K BaxterBaxter Oy
- IrelandPlasma-Lyte 148 & Glucose 5% w/v solution for infusionBaxter Holding B.V.
- IcelandPlasmalyte GlucosBaxter Medical AB*
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Belgium · Plasmalyte 148, Plasmalyte 148 Viaflo
- Bulgaria · Гнак
- Cyprus · Maintelyte, Plasmalyte + Glucose 5%
- Czechia · Gnak, Plasmalyte S Glukózou
- Denmark · Glucose-Na-K Baxter, Plasmalyte
- Spain · Maintelyte, Viaflo Plasmalyte 148 Y Glucosa
- Finland · Glucose-Na-K Baxter, Plasmalyte Glucos
- France · Maintelyte, Plasmalyte Et Glucose
- United Kingdom (Northern Ireland) · Maintelyte, Plasma-Lyte 148
- Greece · Maintelyte, Plasmalyte + Glucose 5%
- Croatia · Gnak, Plasmalyte + Glucose
- Ireland · Maintelyte, Plasma-Lyte 148 & Glucose
- Iceland · Plasmalyte Glucos
- Italy · Crystalglu, Elettrolitica Bilanciata Di Mantenimento Con Glucosio Fresenius Kabi Italia
- Luxembourg · Plasmalyte 148 + Glucose Viaflo, Plasmalyte 148 Viaflo
- Malta · Maintelyte, Plasma-Lyte 148 & Glucose
- Netherlands · Maintelyte, Plasma-Lyte 148 + Glucose
- Norway · Glucose-Na-K Baxter, Karbolytt
- Poland · Gnak
- Portugal · Maintelyte, Plasma-Lyte 148 E Glucose Viaflo
- Romania · Gnak
- Sweden · Glucose-Na-K Baxter, Plasmalyte Glucos
- Slovenia · Gnak, Plasmalyte Z Glukozo
- Slovakia · Gnak, Plasmalyte + Glucose 5%
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d82a2b1-2542-472d-85f5-d4b024801243 GET /v1/drugs/2d82a2b1-2542-472d-85f5-d4b024801243?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate, Glucose Monohydrate Ph. Eur.",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about magnesium chloride hexahydrate, potassium chloride, sodium chloride, sodium acetate trihydrate, glucose monohydrate ph. eur..
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.